Author

Yuli Thamires Magalhães

Universidade de São PauloORCID 0000-0002-3140-5532Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Fábio Luís FortiiD· 3 shared Viktor Kalbermatter BoelliD· 3 shared Diana R.D.C.G. Pacheco· 2 shared Donna Joe Farfan HilaresiD· 1 shared Isabeli Yumi Araújo OsawaiD· 1 shared Jéssica Oliveira FariasiD· 1 shared Laura Lima TuraniiD· 1 shared Lilian C. RussoiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Fábio Luís FortiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

DUSP12 regulates NAT10-mediated RNA acetylation to modulate DNA repair and therapeutic response in hepatocellular carcinoma

Viktor Kalbermatter Boell, Diana R.D.C.G. Pacheco, Yuli Thamires Magalhães, Laura Lima Turani, Isabeli Yumi Araújo Osawa, Nícolas C. Hoch, Fábio Luís Forti

MedComm · Aug 17, 2026Peer-reviewedCancer Biology

Acquisition and reversal of glioblastoma chemoresistance are mediated by the Rho GTPase pathway

Yuli Thamires Magalhães, Viktor Kalbermatter Boell, Fábio Luís Forti

This study shows that Rho GTPase pathway activity and actin cytoskeleton dynamics are critical for chemoresistance in glioblastoma, and their inhibition can reverse resistance to TMZ and CP.

Molecular Cancer Therapeutics · Oct 28, 2025Peer-reviewedCancer Biology

Dual Specificity Phosphatase 3 knockdown drives myeloid leukemia cells to differentiate into macrophages and polarize

Jéssica Oliveira Farias, Diana R.D.C.G. Pacheco, Yuli Thamires Magalhães, Lilian C. Russo, Viktor Kalbermatter Boell, Donna Joe Farfan Hilares, Fábio Luís Forti

This study shows that DUSP3 knockdown promotes differentiation of myeloid leukemia cells into macrophages and alters their polarization markers.

Tissue and Cell · May 3, 2025Peer-reviewedImmunology